Cite
MLA Citation
R. Joe et al.. “The AXL inhibitor, TP-0903, reverses EMT and shows activity in non-small cell lung cancer preclinical models.” European journal of cancer, vol. 174, n.d., pp. S57–S58. http://access.bl.uk/ark:/81055/vdc_100168600225.0x00003b